← Back
Data updated: Mar 10, 2026
WATSON LABS TEVA
CardiovascularNeurologyImmunology
WATSON LABS TEVA is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology. Key products include LEVOTHYROXINE SODIUM.
1974
Since
45
Drugs
-
Trials
287
Approved (2yr)
Recent Activity
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
CARBOPLATIN 2026-02-04
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 43%
6 drugs
Neurology 14%
2 drugs
Immunology 14%
2 drugs
Metabolic 14%
2 drugs
Gastroenterology 14%
2 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Takeda big-pharma
Immunology, Gastroenterology, Neurology, Metabolic
Merck big-pharma
Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Cardiovascular, Metabolic
Amgen biotech
Immunology, Metabolic, Gastroenterology, Neurology
UPJOHN big-pharma
Neurology, Cardiovascular, Metabolic, Immunology
Active (22)
ALVIMOPAN BUPRENORPHINE TERIFLUNOMIDE TRIENTINE HYDROCHLORIDE VALSARTAN AND HYDROCHLOROTHIAZIDE VARDENAFIL HYDROCHLORIDE IBANDRONATE SODIUM ANASTROZOLE TEMOZOLOMIDE SIMVASTATIN ISRADIPINE LEVOTHYROXINE SODIUM BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE DICLOFENAC POTASSIUM GLIPIZIDE ATENOLOL OXAZEPAM DISULFIRAM PROBENECID HYDROCHLOROTHIAZIDE DOXEPIN HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE
Discontinued (22)
CARBOPLATIN FUROSEMIDE MINOCYCLINE HYDROCHLORIDE NAPROXEN CINACALCET HYDROCHLORIDE BICALUTAMIDE ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE THIORIDAZINE HYDROCHLORIDE ISOSORBIDE DINITRATE FENOPROFEN CALCIUM CARISOPRODOL CIMETIDINE LEVOFLOXACIN ESTROPIPATE NORETHINDRONE AND ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) DEXAMETHASONE ACETATE CHLORPROPAMIDE AFEDITAB CR DIMENHYDRINATE ACETOHEXAMIDE
Company Info
- First Approval
- 1974-01-29
- Latest
- 2026-02-03
- Applications
- 51